Literature DB >> 2756985

Lower esophageal sphincter dysfunction in diffuse esophageal spasm.

S Campo1, M Traube.   

Abstract

Although lower esophageal sphincter (LES) dysfunction has been reported in patients with diffuse esophageal spasm, recent changes in manometric criteria for spasm and for LES relaxation suggested a need for reassessment. Moreover, LES relaxation in reflux-associated spasm has not been reported previously. On clinical criteria and independent of manometric findings, 22 patients with spasm were assigned to either idiopathic (I-DES, N = 9) or reflux-associated spasm (R-DES, N = 13) groups. Patients who underwent manometry for chest pain (C-NL, N = 10) or reflux (R-NL, N = 10) and had normal peristalsis served as control groups. Percent LES relaxation was significantly reduced in both spasm groups, and R-DES had significantly lower percent relaxation than I-DES. Post-deglutitive nadir sphincter pressure was significantly greater in R-DES than in I-DES. Duration of relaxation was normal in I-DES, but was significantly decreased in R-DES. This study indicates that 1) LES relaxation may be impaired in I-DES patients meeting current criteria for spasm, 2) the impairment in I-DES is primarily in "amplitude" of relaxation, i.e., percent relaxation and nadir pressure, but not duration, 3) LES relaxation may also be impaired in R-DES, and 4) the impairment in R-DES is to a greater degree than in I-DES patients and may be seen in both "amplitude" and duration of relaxation. This study shows that there is a spectrum of sphincter dysfunction in patients with esophageal spasm. It also suggests that there may be separate mechanisms for LES relaxation in R-DES patients, one with impaired relaxation and the other with near complete relaxation, "transient" or otherwise, to allow for reflux.

Entities:  

Mesh:

Year:  1989        PMID: 2756985

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  9 in total

1.  Discussion on the esophageal manometric characteristics of idiopathic and reflux-associated esophageal spasm.

Authors:  Salvatore M A Campo
Journal:  Dig Dis Sci       Date:  2012-06       Impact factor: 3.199

Review 2.  Endoscopy in the diagnosis and management of motility disorders.

Authors:  Yael Kopelman; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2011-02-01       Impact factor: 3.199

3.  Esophageal dysmotility and gastroesophageal reflux in intrinsic asthma.

Authors:  S Campo; S Morini; M A Re; D Monno; R Lorenzetti; B Moscatelli; E Bologna
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

4.  On drugs and dilators for achalasia.

Authors:  M Traube
Journal:  Dig Dis Sci       Date:  1991-03       Impact factor: 3.199

5.  Effects of intraluminal acidification on oesophageal motor activity.

Authors:  I Bontempo; L Piretta; E Corazziari; F Michetti; F Anzini; A Torsoli
Journal:  Gut       Date:  1994-07       Impact factor: 23.059

Review 6.  Current concepts on pathophysiology, diagnosis and treatment of diffuse oesophageal spasm.

Authors:  M Storr; H D Allescher; M Classen
Journal:  Drugs       Date:  2001       Impact factor: 9.546

7.  Decreased sympathetic inhibition in gastroesophageal reflux disease.

Authors:  S M Campo; A Capria; F Antonucci; G Martino; A Ciamei; P M Rossini; E Bologna; D Cannata
Journal:  Clin Auton Res       Date:  2001-02       Impact factor: 4.435

8.  Long esophageal myotomy with a fundic patch procedure for treating diffuse esophageal spasm: report of a case.

Authors:  N Sato; M Watanabe; S Mastuno; N Nishinari; A Sasaki; K Saito; S Sasaki; K Sato; S Mori
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

9.  Comparison of the esophageal manometric characteristics of idiopathic and reflux-associated esophageal spasm: evaluation by 24-hour ambulatory esophageal motility and pH monitoring.

Authors:  Haruo Hayashi; Kazunori Mine; Masako Hosoi; Osamu Tsuchida; Masanori Handa; Naoko Kinukawa; Katsumi Andou; Chiharu Kubo
Journal:  Dig Dis Sci       Date:  2003-11       Impact factor: 3.199

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.